Conference · Dubai, United Arab Emirates
Market Access and HTA: What Every Pharmaceuticals Stakeholder Should Know
Advertising, Marketing · Pharmaceuticals
Key numbers
- Editions on record
- 1first in 2016
About Market Access and HTA: What Every Pharmaceuticals Stakeholder Should Know
Today, manufacturers face many challenges and opportunities when dealing with the innovative approaches to demonstrate a value and affordability of a pharmaceutical product to other stakeholders. Key elements for successful delivery of value and affordability include market access and HTA (Health Technology Assessment). Market access is a process of identifying, creating and communication value to the key stakeholders. The global value needs to reflect on a local level, thus remaining relevant to the local setting. The setting specific value is reflected through HTA processes.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2016 | 12–13 Dec 2016 | Four Points by Sheraton Dubai Dubai, United Arab Emirates | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Market Access and HTA: What Every Pharmaceuticals Stakeholder Should Know?
The next dates haven't been confirmed. The last edition we have on record was 12–13 Dec 2016.
Where is it held?
The last edition we have was at Four Points by Sheraton Dubai, Dubai, United Arab Emirates.